Niki BioSolutions, Inc. (NIKI) Stock Analysis & Investment Frameworks

Niki BioSolutions, Inc. (NIKI) stock analysis on Invetso. Review Niki BioSolutions, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Niki BioSolutions, Inc. Company Overview

Niki BioSolutions, Inc. Key Financial Metrics

About Niki BioSolutions, Inc.

Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.

Niki BioSolutions, Inc. Investment Frameworks

Invetso analyzes Niki BioSolutions, Inc. (NIKI) across the following frameworks:

Explore More NIKI Research